Skip to search formSkip to main contentSkip to account menu

YM 16638

Known as: YM-16638 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Thiadiazoles
YM 638

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Effect of the hypocholesterolemic agent YM-16638 on cholesterol biosynthesis activity and apolipoprotein B secretion in HepG2 and monkey liver.
YM-16638 ([[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl]thio]-1,3,4-++ +thiadiazol-2-yl] thio] acetic acid) showed a strong… 
1996
1996
Species specificity in the blood cholesterol‐lowering effect of YM‐16638
1 . The compound YM‐16638, [[5‐[[3‐(4‐acetyl‐3‐hydroxy‐2‐propylphenoxy)propyl]thio]‐1,3,4‐thiadiazol‐ 2‐yl]thio] acetic acid was… 
1991
1991
Characterization of sulfidopeptide leukotriene responses in sheep tracheal smooth muscle in vitro.
We have investigated the effects of leukotrienes (LTs) on isolated tracheal smooth muscle from sheep sensitive to Ascaris suum… 
1991
1991
Pharmacological modulation of endothelin‐induced contraction of guinea‐pig isolated airways and thromboxane release
1 The aim of the present experiments was to study the possible involvement of known bronchoconstrictor substances in mediating… 
1989
1989
The effect of an orally active leukotriene (LT) antagonist YM-16638 on antigen-induced early and late airway responses in allergic sheep.
1988
1988
Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
The anti-leukotriene effect of [[5-[[3-(4-acetyl-3-hydroxy -2- propylphenoxy)propyl] thio]-1,3,4-thiadiazol-2-yl] thio] acetic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)